Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea · Delayed Price · Currency is KRW 3,600.00
-15.00 (-0.42%)
Aug 14, 2025, 2:40 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 38.67 billion as of August 14, 2025. Its market cap has decreased by -57.14% in one year.
Market Cap
38.67B
Enterprise Value
38.51B
Revenue
1.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,600.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 38.67B, a decrease of -57.14%. That is a compound annual growth rate of -54.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 39.38B | -11.28% |
| Dec 30, 2024 | 44.38B | -50.80% |
| Jul 15, 2024 | 90.22B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.67T |
| Celltrion | 38.01T |
| ALTEOGEN | 23.22T |
| Yuhan | 8,309.02B |
| SK Biopharmaceuticals | 7,737.35B |
| Peptron | 7,117.34B |
| PharmaResearch | 6,950.67B |
| LigaChem Biosciences | 5,361.69B |